Risk factors for skin rash among patients with cancer receiving epidermal growth factor receptor inhibitors: a scoping review protocol

Key Points

• This review aims to identify and summarize risk factors associated with skin rash in cancer patients treated with epidermal growth factor receptor inhibitors.
• Conduct a scoping review using published and publicly available sources
• Analyze existing literature on risk factors for skin rash
• Disseminate findings through various academic channels
• Study does not present results yet as it is a protocol
• Findings will inform clinical practices upon completion
• Results may highlight specific demographic or treatment-related risk factors

Abstract